Purified Water Generation Systems in the Pharmaceutical Industry

The pharmaceutical industry uses pure water in various ways. It can be employed in the formulation of non-parenteral products as well as the last washing of containers and process machinery. It may be employed in the initial washing of containers and the feeding of WFI systems during the production of parenteral goods. It is thus important to understand the purified water generation system in the pharmaceutical industry.

While there are several purified water generation processes, the main objective of all the operations are:

  • cGMP compliance
  • Adhering to the guidelines set by the global pharmacopoeias
  • Upholding on-site specifications
  • Sanitary in-line instrumentation 

What is Purified Water in Pharma?

The term “purified water” is frequently used in pharmaceutical operations. Simply put, it is a type of pharmaceutical-grade water that is frequently employed as an excipient in the manufacturing of sterile and pyrogenic medications.

Different Purified Water Generation Systems in Pharmaceutical Industry

Pure water generation systems in pharma are usually designed keeping in mind the scope and scale of the plant and the end-use product specifications. One of the first steps in the purified water generation system in the pharmaceutical industry is the pre-treatment. Depending on the quality of the feed water and the requirement of the process, the pre-treatment stage may include the following processes:

Chlorination

An anti-oxidant such as chlorine is added to the water to eliminate bacteria and viruses. 

Dosing System

Three key goals are achieved during the dosing process. To prevent the water’s silica, sulphates, and other precipitates from fouling the filter membranes, an anti-scalent dosage is used by adding sodium hexametaphosphates. After that, acids like acetic acid and hydrochloric acid are added to the water to remove carbon dioxide. This is called the pH correction dosage. The chlorine that was added during the chlorination process is additionally removed from the water by adding SMBS, or sodium metabisulfite, as chlorine could corrode the RO membranes in the pipes.

Commonly-Used Purified Water Generation System Designs in Pharma

After the water is suitably pre-treated, different purified water generation systems in the pharmaceutical industry are undertaken for further purification. 

Reverse Osmosis or RO

Reverse osmosis is one of the most commonly used different purified water generation systems in the pharmaceutical industry and is considered one of the best methods for filtration. 

Using semi-permeable membranes, reverse osmosis forces the water to the diluted side by interrupting the water’s normal osmotic flow. The reverse osmosis membranes are typically constructed of cellulose acetate and have incredibly small pores that allow water to pass through while trapping bacteria. The water rejects the impurities as it travels through the membranes when a high-pressure pump is used to force the water through. Additionally, it is crucial to make sure that the membranes utilised in the procedure need particular sanitization techniques. Microbial pollutants are removed from the membranes while they are being rinsed with hot water that is 80 degrees Celsius. Inorganic contaminants that could impair the quality of the water being carried through the membranes are removed using acids like citric acid.

RO is effective at removing salts, sugars, dyes, bacteria, other particles, microorganisms, trihalomethanes, pesticides, and volatile organic compounds. However, it cannot eliminate the dissolved gases in the water, such as carbon dioxide.

Electrodeionisation or EDI

EDI is a popular and cost-effective method used for the manufacturing of high-purity water in pharma. 

Ion exchange and electrolysis form the basis of the de-ionization process. Its major goal is to remove particular ions from the water and swap them out for more preferable ions.

Different ions, or molecules and atoms with various charges, can be found in water. The terms “cations” and “anions” are used to describe the positive and negative charges of ions, respectively. Ion-exchanging membranes, which are essentially high surface electrodes with positive and negative charges, are used to separate the ion exchange resin beds that are used to set up the EDI module. The positively charged cation flows toward the negatively charged anode, and the negatively charged anions move toward the positively charged cathode, causing the water to become de-ionized when an electric current is sent through it at a right angle.

De-ionization efficiently eliminates water-dissolved pollutants such as salts, minerals, and organic contaminants.

Distillation

Distillation makes use of the volatility (difference in vapour pressures) of the water and contaminants that are suspended in it. In a multi-column distillation facility that has been properly developed, the water is boiled, and the vapours are condensed to obtain clean and sterile water.

Water for injection is one of the main applications for the purified water produced by the distillation process, as distillation is capable of removing endotoxins from the water. Water for injection (WFI) is a type of pharmaceutical water that is suitable for putting pharmaceuticals or treatments right into patients’ bloodstreams.

Ultra-violet Disinfection

UV disinfection is one of the low-cost and quick methods of producing high-purity water. In this procedure, pathogens such as bacteria, viruses, algae, moulds, etc., are removed from the water by exposing it to UV radiation of particular wavelengths using a UV lamp.

Cleaning in Place (CIP), a technique used in the pharmaceutical industry to make sure the vessels, equipment, pipes, filters, and other paraphernalia are safe to be used for various pharma operations, is one of the primary applications of UV disinfection outside of the manufacture of healthcare products.

TSA has almost 20 years of experience delivering optimized purified water solutions at the lowest cost per litre. Our team can support you at every stage, from design and installation and validation to after-sales support.

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.